Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention
- 1 June 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 8 (6) , 967-974
- https://doi.org/10.1586/14737140.8.6.967
Abstract
(2008). Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention. Expert Review of Anticancer Therapy: Vol. 8, No. 6, pp. 967-974.Keywords
This publication has 39 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potentialProceedings of the National Academy of Sciences, 2007
- The JNK signal transduction pathwayCurrent Opinion in Cell Biology, 2007
- Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2Proceedings of the National Academy of Sciences, 2007
- Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2Nature, 2007
- Signalling via integrins: Implications for cell survival and anticancer strategiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- alpha6 Integrin Cleavage: Sensitizing human prostate cancer to ionizing radiationInternational Journal of Radiation Biology, 2007
- Combination of integrin siRNA and irradiation for breast cancer therapyBiochemical and Biophysical Research Communications, 2006
- β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injuryOncogene, 2005
- Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrinsThe Journal of cell biology, 2004